VALUE	SUBSTRATE	BRENDA	INCHI	TEMP	PH	MUTATION	NOTES
1.4	acetamide	810	DLFVBJFMPXGRIB-UHFFFAOYSA-N				
20	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N	236		X	G202S/Q207H/R236C/R369M/Q382E mutant
51	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N			X	G202A/Q207H/Q382E mutant
76	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N			X	Q207H/S316N/I437N mutant
78	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N			X	T31I/I437N mutant
85	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N			X	I437N mutant
125	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N			X	Q207H/S316N/Q382E mutant
150	(R)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N				; wild-type
8.8	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N	236		X	G202S/Q207H/R236C/R369M/Q382E mutant
18	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N			X	G202A/Q207H/Q382E mutant
43	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N			X	Q207H/S316N/Q382E mutant
82	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N				; wild-type
89	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N			X	Q207H/S316N/I437N mutant
101	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N			X	I437N mutant
108	(S)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N			X	T31I/I437N mutant
25	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N			X	T31I/I437N mutant
29	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N			X	I437N mutant
43	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N				; wild-type
64	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N			X	Q207H/S316N/I437N mutant
76	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N	236		X	G202S/Q207H/R236C/R369M/Q382E mutant
78	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N			X	Q207H/S316N/Q382E mutant
165	(R)-lactamide	3089	SXQFCVDSOLSHOQ-UWTATZPHSA-N			X	G202A/Q207H/Q382E mutant
19	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N				; wild-type
39	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N			X	I437N mutant; T31I/I437N mutant
40	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N	236		X	G202S/Q207H/R236C/R369M/Q382E mutant
49	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N			X	Q207H/S316N/I437N mutant
54	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N			X	Q207H/S316N/Q382E mutant
88	(S)-lactamide	3090	SXQFCVDSOLSHOQ-REOHCLBHSA-N			X	G202A/Q207H/Q382E mutant
2	Pentanamide	4086	IPWFJLQDVFKJDU-UHFFFAOYSA-N				
46	2-phenylacetamide	1506	LSBDFXRDZJMBSC-UHFFFAOYSA-N				
0.04	cyclohexanecarboxamide	8841	PNZXMIKHJXIPEK-UHFFFAOYSA-N				
0.031	(S)-(+)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N	30	7.8		at 30C and pH 7.8
4.4	(S)-(+)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N				
7.73	(S)-(+)-mandelamide	2517	MAGPZHKLEZXLNU-ZETCQYMHSA-N	30	7.8		at 30C and pH 7.8
2.8	Caproamide	3940	ALBYIUDWACNRRB-UHFFFAOYSA-N				
10.2	(R)-(-)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N				
4.6	propanamide	1338	QLNJFJADRCOGBJ-UHFFFAOYSA-N				
16.1	(R)-(+)-mandelamide	2412	MAGPZHKLEZXLNU-SSDOTTSWSA-N	30	7.8		at 30C and pH 7.8
27	(S)-2-aminophenylacetamide	25774	KIYRSYYOVDHSPG-ZETCQYMHSA-N				
25	(R)-2-aminophenylacetamide	2171	KIYRSYYOVDHSPG-SSDOTTSWSA-N				
1.1	2-cyclohexylacetamide	25775	DKLQJNUJPSHYQG-UHFFFAOYSA-N				
0.61	butanamide	2373	DNSISZSEWVHGLH-UHFFFAOYSA-N				
